Prognostic significance of tumour budding, tumour-stroma ratio and desmoplastic stromal reaction in gall bladder carcinoma

被引:6
|
作者
Goyal, Surbhi [1 ]
Banga, Priyanka [1 ]
Meena, Nisha [1 ]
Chauhan, Geeta [1 ]
Sakhuja, Puja [1 ]
Agarwal, Anil Kumar [2 ]
机构
[1] Govind Ballabh Pant Inst Postgrad Med Educ & Res, Pathol, Delhi, India
[2] Govind Ballabh Pant Inst Postgrad Med Educ & Res, Gastrointestinal Surg, Delhi, India
关键词
gallbladder neoplasms; stromal cells; pathology; surgical; CANCER; SURVIVAL; MICROENVIRONMENT; CATEGORIZATION;
D O I
10.1136/jclinpath-2021-207957
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims and methods The prognostic role of tumour budding (TBd) and its interaction with the stromal microenvironment has gained a lot of attention recently, but remains unexplored in gall bladder cancer (GBC). We aimed to study the interrelationship of TBd by International Tumour Budding Consensus Conference scoring system, tumour-stroma ratio (TSR) and desmoplastic stromal reaction (DSR) with the conventional clinicopathological prognostic factors, mortality and overall survival (OS) in 96 patients of operated GBC. Results Higher age, high TNM stage, lymphovascular and perineural invasion, positive resection margins, higher TBd score, low TSR and immature DSR were significantly associated with worse OS. However, on multivariate analysis, only metastases, positive resection margins and TSR <50% proved to be independent prognostic factors. The TBd score of stroma-rich tumour group (6.40 +/- 4.69) was significantly higher than that of stroma-poor group (2.77 +/- 3.79, p <= 0.001). The TBd score of immature and intermediate DSR groups was significantly higher than that of mature group (p <= 0.001 and p=0.002, respectively). There was a strong interobserver agreement for TBd score, TSR and type of DSR (Cohen's Kappa=0.726 to 0.864, p <= 0.001). Stroma-rich tumours were significantly associated with immature DSR and fibrotic DSR with high TSR (p <= 0.001). Conclusion A high TBd, low TSR and immature DSR were significantly associated with several high-risk clinicopathological parameters and poor OS in GBC. These novel, simple, reproducible and cost-effective parameters may be included in the routine reporting checklist for GBC as additional prognostic parameters that can substratify the high-risk patients.
引用
收藏
页码:308 / 314
页数:7
相关论文
共 50 条
  • [1] Tumour budding and tumour-stroma ratio in hepatocellular carcinoma
    Kairaluoma, Valtteri
    Kemi, Niko
    Pohjanen, Vesa-Matti
    Saarnio, Juha
    Helminen, Olli
    BRITISH JOURNAL OF CANCER, 2020, 123 (01) : 38 - 45
  • [2] The prognostic significance of tumour-stroma ratio in endometrial carcinoma
    Panayiotou, Hannah
    Orsi, Nicolas M.
    Thygesen, Helene H.
    Wright, Alexander I.
    Winder, Matthew
    Hutson, Richard
    Cummings, Michele
    BMC CANCER, 2015, 15
  • [3] The prognostic significance of tumour-stroma ratio in endometrial carcinoma
    Hannah Panayiotou
    Nicolas M. Orsi
    Helene H. Thygesen
    Alexander I. Wright
    Matthew Winder
    Richard Hutson
    Michele Cummings
    BMC Cancer, 15
  • [4] Prognostication for oral squamous cell carcinoma patients based on the tumour-stroma ratio and tumour budding
    Dourado, Mauricio R.
    Miwa, Karen Y. M.
    Hamada, Guilherme B.
    Paranaiba, Livia M. R.
    Sawazaki-Calone, Iris
    Domingueti, Catherine B.
    de Oliveira, Carine Ervolino
    Furlan, Emylle C. B.
    Longo, Bruna C.
    Almangush, Alhadi
    Salo, Tuula
    Coletta, Ricardo D.
    HISTOPATHOLOGY, 2020, 76 (06) : 906 - 918
  • [5] The prognostic value of the tumour-stroma ratio in invasive breast carcinoma
    Mesker, W. E.
    Vangangelt, K.
    Tollenaar, L.
    van Pelt, G.
    Dekker, T.
    Kuppen, P.
    Tollenaar, R.
    VIRCHOWS ARCHIV, 2018, 473 : S52 - S52
  • [6] The prognostic value of the tumour-stroma ratio in invasive breast carcinoma
    Mesker, W. E.
    Vangangelt, K.
    Tollenaar, R.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S48 - S48
  • [7] Tumour budding and tumour–stroma ratio in hepatocellular carcinoma
    Valtteri Kairaluoma
    Niko Kemi
    Vesa-Matti Pohjanen
    Juha Saarnio
    Olli Helminen
    British Journal of Cancer, 2020, 123 : 38 - 45
  • [8] Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study
    Marloes A. Smit
    Gabi W. van Pelt
    Valeska Terpstra
    Hein Putter
    Rob A. E. M. Tollenaar
    Wilma E. Mesker
    J. Han J. M. van Krieken
    International Journal of Colorectal Disease, 2021, 36 : 2729 - 2737
  • [9] Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study
    Smit, Marloes A.
    van Pelt, Gabi W.
    Terpstra, Valeska
    Putter, Hein
    Tollenaar, Rob A. E. M.
    Mesker, Wilma E.
    van Krieken, J. Han J. M.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2021, 36 (12) : 2729 - 2737
  • [10] Prognostic value of tumour-stroma ratio in colorectal carcinomas
    Hmidi, A.
    Khanchel, F.
    Helal, I.
    Ben Thayer, M.
    Ben Brahim, E.
    Chadli-Debbiche, A.
    VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S87 - S88